ThinSol - About the company
ThinSol is a series A company based in Hyderabad (India), founded in 2017. It operates as a Provider of oral thin strips for bioavailability and discreet administration. ThinSol has raised $4.59M in funding from Reddy Growth, with a current valuation of $*****. The company has 72 active competitors, including 15 funded and 13 that have exited. Its top competitors include companies like Cure Pharmaceutical, Cingulate and Orbis Medicines.
Company Details
Provider of oral thin strips for bioavailability and discreet administration. The company uses ThinSol technology for creating oral strips that deliver supplements in a thin, dissolvable form.
- Website
- thinsol.com
- Registered Address
- PLOT NO 109/3, PHASE-II, SECTOR 2, LANE NO.6 IDA CHERLAPALLY, Hyderabad, HYDERABAD, Telangana, India, 500051
Key Metrics
Founded Year
2017
Location
Hyderabad, India
Stage
Series A
Total Funding
$4.59M in 1 round
Latest Funding Round
Post Money Valuation
$***** as on Apr 18, 2022
Investors
Ranked
9th among 72 active competitors
Annual Revenue
₹10 - ₹50 Cr as on Mar 31, 2024
Employee Count
72 as on Apr 30, 2025
Legal entities associated with ThinSol
ThinSol is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
AAVISHKAR ORAL STRIPS PRIVATE LIMITED CIN: U24100TG2013PTC089852 , India, Active | Sep 04, 2013 | ₹10 - ₹50 Cr (As on Mar 31, 2024) | 81 (As on Apr 01, 2026) |
Sign up to download ThinSol's company profile
ThinSol's funding and investors
ThinSol has raised a total funding of $4.59M over 1 round. Its latest funding round was a Series A round on Apr 18, 2022 for $*****. 4 investors participated in its latest round. ThinSol has 1 institutional investor and 8 angel investors.
Here is the list of recent funding rounds of ThinSol:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 18, 2022 | 8262443 | Series A | 9422791 | 6100028 | 9429112 | 1856014 |
Access funding benchmarks and valuations. Sign up today!View details of ThinSol's funding rounds and investors
ThinSol's founders and board of directors
Founder? Claim ProfileThinSol's employee count trend
ThinSol has 72 employees as of Apr 25. The total employee count is 20.0% more than what it was in Apr 24. Here is ThinSol's employee count trend over the years:
Uncover ThinSol's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ThinSol's Competitors and alternates
Top competitors of ThinSol include Cure Pharmaceutical, Cingulate and Orbis Medicines. Here is the list of Top 10 competitors of ThinSol, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Cure Pharmaceutical 2010, Oxnard (United States), Public | Developer of oral thin film based drug delivery systems | $9.65M | 62/100 | |
2nd |  Cingulate 2012, Kansas City (United States), Public | Developer of therapeutics for the treatment of ADHD | $33M | 58/100 | |
3rd | Orbis Medicines 2022, Copenhagen (Denmark), Series A | Provider of drug discovery platform to develop multiple therapeutics | $126M | 54/100 | |
4th | Vivtex 2018, Cambridge (United States), Seed | Developer of oral drug delivery system | $1.8M | - | 53/100 |
5th | PLx Pharma 2002, Sparta (United States), Public | Developer of drug delivery platform to treat gastrointestinal diseases | $25.3M | 52/100 | |
6th | Developer of oral reformulations to treat various health conditions | - | 51/100 | ||
7th |  Ingenus 2010, Orlando (United States), Unfunded | Developer of oral drug delivery and drugs for treating cancer | - | - | 49/100 |
8th |  G2GBIO 2017, Yuseong District (South Korea), Public | Developer of sustained release injectables | - | 48/100 | |
9th | Provider of oral thin strips for bioavailability and discreet administration | $4.59M | 46/100 | ||
10th | Lipocine 1997, Salt Lake City (United States), Public | Develops oral versions of hormones using Hydroance drug delivery technology | $38M | 45/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on ThinSol's competitors? Click here to see the top ones
ThinSol's Latest cap tables and shareholding
Founders (largest shareholder) own 54.14%, Enterprises own 12.86%, Angels own 20.42% and Other People own 12.59%. The net worth of ThinSol's founders is INR 60.7Cr as of Apr 18, 2022.
Shareholders Name | Post Round Holding % | Net worth | Cumulative Investment | Realised Returns | Unrealised Returns | Return Multiple |
|---|---|---|---|---|---|---|
Founder | 54.14% | 60.7Cr | 1816466 | 3306587 | 6512379 | 7037792 |
Enterprise | 12.86% | 14.4Cr | 7850611 | 3923378 | 8303964 | 4423246 |
Angel | 20.42% | 22.9Cr | 8949742 | 8905329 | 2091948 | 9116370 |
5117893 | 9029328 | 6698657 | 3372166 | 8816334 | 8221433 | |
Other People | 12.59% | 14.1Cr | 7451374 | 6968013 | 7771294 | 3273433 |
Total | 100.00% | 112Cr | 6635503 | 7285001 | 2216568 | 5799655 |
To unlock detailed Cap Table of ThinSol Sign up today!Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
DisclaimerView more details of ThinSol's Shareholding
ThinSol's Investments and acquisitions
ThinSol has made no investments or acquisitions yet.
Reports related to ThinSol
Here is the latest report on ThinSol's sector:
Are you a Founder ?
FAQs about ThinSol
Explore our recently published companies
- Agilator - Unfunded company
- Community & Environmental - Laos based, 1998 founded, Unfunded company
- Tideline Cabinets - Unfunded company
- Artisan Code - Sweden based, Unfunded company
- CryptoRecruit - Sydney based, 2017 founded, Unfunded company
- XVerse - Kolkata based, 2020 founded, Unfunded company
